Showing 35,310 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined aidsmap in 2008 and was Managing Editor from 2018 to 2024. As a freelancer, he now edits aidsmap’s news and conference coverage, as well as working on updates to About HIV pages. He is also a contributing science editor for TheBodyPro, a freelance journalist for The Lancet HIV, and a medical writer helping researchers prepare articles for peer-reviewed journals. He began working on HIV at Gay Men Fighting AIDS in the mid-1990s.

Activism & civil society

Tribute to Bob Munk: long-time HIV positive US treatment activist and educator

Editor's pick
HIV i-Base
21 July 2015
Access to healthcare

IAS 2015: While “game-changing,” START trial draws “line in the sand” and sets “time a’ ticking” to stop preventable illnesses and death, calls for action are accompanied by questions of impact of inequities, obstacles

Editor's pick
Science Speaks
21 July 2015
Starting treatment

START trial provides definitive evidence of the benefits of early HIV treatment

News
21 July 2015
Retention & linkage to care

Innovative approaches to linkage to care boost clinic visits, HIV treatment uptake in African study

News
21 July 2015
PrEP science

Non-daily PrEP regimens provide extra options, but adherence is often better with daily dosing

News
21 July 2015
The search for a cure

Targets proliferate in HIV cure research

News
21 July 2015
Undetectable viral load & treatment as prevention

No HIV infections from partners with fully suppressed viral load during long-term follow up of landmark treatment as prevention trial

News
21 July 2015
The search for a cure

Young woman stays undetectable for twelve years off treatment after early HIV therapy

News
21 July 2015
TB transmission & prevention

Presumptive treatment of TB in advanced HIV no better than giving ART and isoniazid

News
21 July 2015
Hepatitis C treatment

How Sure Is a Cure?

Editor's pick
Poz
20 July 2015
Access to healthcare

Latin America Has Beaten Down, but not Beaten, HIV/AIDS

Editor's pick
IPS News
20 July 2015
HIV treatment

European Commission Approves Bristol-Myers Squibb’s Evotaz (atazanavir and cobicistat fixed-dose combination) for the Treatment of HIV-1 Infection in Adults

Editor's pick
BMS press release
20 July 2015
Hepatitis C treatment

Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers

Editor's pick
Wall Street Journal Pharmalot blog
20 July 2015
Health services & systems

Russia’s Scientific Squeeze Out

Editor's pick
The Scientist
20 July 2015
UK health services

Terrence Higgins Trust trustee to become its interim chief executive

Editor's pick
Civil Society
20 July 2015
Hepatitis & HIV

Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection

News
20 July 2015
PrEP programmes & uptake

Vancouver Consensus Statement calls for early access to treatment and PrEP worldwide

News
20 July 2015
HIV testing policies & guidelines

World Health Organization urges more HIV testing by non-medical staff, outside of clinical settings, targeted to those who need it the most

News
20 July 2015
Treatment guidelines

World Health Organization to recommend HIV treatment for all

News
20 July 2015
HIV prevention policy

Test and treat studies and African countries showing that 90-90-90 targets are achievable

News
20 July 2015
HIV testing policies & guidelines

Consolidated guidelines on HIV testing services

Editor's pick
World Health Organization
19 July 2015
PrEP

Investment in post-efficacy R&D critical for PrEP, other new HIV prevention options

Editor's pick
AVAC
19 July 2015
Mental & emotional health problems

Schizophrenia and HIV—Study underscores serious issues associated with dual diagnoses

Editor's pick
CATIE
19 July 2015
Hepatitis C treatment

Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers

Editor's pick
Wall Street Journal
19 July 2015